299 related articles for article (PubMed ID: 20702611)
1. Targeting eukaryotic translation initiation factor 4E (eIF4E) in cancer.
Hsieh AC; Ruggero D
Clin Cancer Res; 2010 Oct; 16(20):4914-20. PubMed ID: 20702611
[TBL] [Abstract][Full Text] [Related]
2. Eukaryotic translation initiation factor 4E as a novel therapeutic target in hematological malignancies and beyond.
Pettersson F; Del Rincon SV; Miller WH
Expert Opin Ther Targets; 2014 Sep; 18(9):1035-48. PubMed ID: 25004955
[TBL] [Abstract][Full Text] [Related]
3. Targeting the oncogene eIF4E in cancer: From the bench to clinical trials.
Borden KL
Clin Invest Med; 2011 Dec; 34(6):E315. PubMed ID: 22129918
[TBL] [Abstract][Full Text] [Related]
4. eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies.
Alain T; Morita M; Fonseca BD; Yanagiya A; Siddiqui N; Bhat M; Zammit D; Marcus V; Metrakos P; Voyer LA; Gandin V; Liu Y; Topisirovic I; Sonenberg N
Cancer Res; 2012 Dec; 72(24):6468-76. PubMed ID: 23100465
[TBL] [Abstract][Full Text] [Related]
5. Targeting the eukaryotic translation initiation factor 4E for cancer therapy.
Graff JR; Konicek BW; Carter JH; Marcusson EG
Cancer Res; 2008 Feb; 68(3):631-4. PubMed ID: 18245460
[TBL] [Abstract][Full Text] [Related]
6. Structure and functions of the translation initiation factor eIF4E and its role in cancer development and treatment.
Piserà A; Campo A; Campo S
J Genet Genomics; 2018 Jan; 45(1):13-24. PubMed ID: 29396141
[TBL] [Abstract][Full Text] [Related]
7. Suppression of oncogenic protein translation via targeting eukaryotic translation initiation factor 4E overcomes chemo-resistance in nasopharyngeal carcinoma.
Xu M; Tao Z; Wang S; Jiang Y; Qu M
Biochem Biophys Res Commun; 2019 May; 512(4):902-907. PubMed ID: 30929914
[TBL] [Abstract][Full Text] [Related]
8. The Eukaryotic Translation Initiation Factor 4E (eIF4E) as a Therapeutic Target for Cancer.
Karaki S; Andrieu C; Ziouziou H; Rocchi P
Adv Protein Chem Struct Biol; 2015; 101():1-26. PubMed ID: 26572974
[TBL] [Abstract][Full Text] [Related]
9. Eukaryotic initiation factor 4E (eIF4E): A recap of the cap-binding protein.
Batool A; Aashaq S; Andrabi KI
J Cell Biochem; 2019 Sep; 120(9):14201-14212. PubMed ID: 31074051
[TBL] [Abstract][Full Text] [Related]
10. Cap in hand: targeting eIF4E.
Fischer PM
Cell Cycle; 2009 Aug; 8(16):2535-41. PubMed ID: 19597330
[TBL] [Abstract][Full Text] [Related]
11. A cell-penetrant lactam-stapled peptide for targeting eIF4E protein-protein interactions.
Gallagher EE; Menon A; Chmiel AF; Deprey K; Kritzer JA; Garner AL
Eur J Med Chem; 2020 Nov; 205():112655. PubMed ID: 32739551
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic targeting of eukaryotic initiation factor (eIF) 4E.
Pelletier J; Sonenberg N
Biochem Soc Trans; 2023 Feb; 51(1):113-124. PubMed ID: 36661272
[TBL] [Abstract][Full Text] [Related]
13. Antisense oligonucleotide targeting eukaryotic translation initiation factor 4E reduces growth and enhances chemosensitivity of non-small-cell lung cancer cells.
Thumma SC; Jacobson BA; Patel MR; Konicek BW; Franklin MJ; Jay-Dixon J; Sadiq A; De A; Graff JR; Kratzke RA
Cancer Gene Ther; 2015 Aug; 22(8):396-401. PubMed ID: 26227824
[TBL] [Abstract][Full Text] [Related]
14. Mitosis-related phosphorylation of the eukaryotic translation suppressor 4E-BP1 and its interaction with eukaryotic translation initiation factor 4E (eIF4E).
Sun R; Cheng E; Velásquez C; Chang Y; Moore PS
J Biol Chem; 2019 Aug; 294(31):11840-11852. PubMed ID: 31201269
[TBL] [Abstract][Full Text] [Related]
15. eIF4E-mediated translational control of cancer incidence.
Bitterman PB; Polunovsky VA
Biochim Biophys Acta; 2015 Jul; 1849(7):774-80. PubMed ID: 25263391
[TBL] [Abstract][Full Text] [Related]
16. Targeting translation: eIF4E as an emerging anticancer drug target.
Lu C; Makala L; Wu D; Cai Y
Expert Rev Mol Med; 2016 Jan; 18():e2. PubMed ID: 26775675
[TBL] [Abstract][Full Text] [Related]
17. Mnks, eIF4E phosphorylation and cancer.
Proud CG
Biochim Biophys Acta; 2015 Jul; 1849(7):766-73. PubMed ID: 25450520
[TBL] [Abstract][Full Text] [Related]
18. The Structures of eIF4E-eIF4G Complexes Reveal an Extended Interface to Regulate Translation Initiation.
Grüner S; Peter D; Weber R; Wohlbold L; Chung MY; Weichenrieder O; Valkov E; Igreja C; Izaurralde E
Mol Cell; 2016 Nov; 64(3):467-479. PubMed ID: 27773676
[TBL] [Abstract][Full Text] [Related]
19. Dynamic Interaction of Eukaryotic Initiation Factor 4G1 (eIF4G1) with eIF4E and eIF1 Underlies Scanning-Dependent and -Independent Translation.
Haimov O; Sehrawat U; Tamarkin-Ben Harush A; Bahat A; Uzonyi A; Will A; Hiraishi H; Asano K; Dikstein R
Mol Cell Biol; 2018 Sep; 38(18):. PubMed ID: 29987188
[TBL] [Abstract][Full Text] [Related]
20. The oncogene eIF4E: using biochemical insights to target cancer.
Carroll M; Borden KL
J Interferon Cytokine Res; 2013 May; 33(5):227-38. PubMed ID: 23472659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
